Trust in healthcare starts with being able to show your sources. This section is the central library behind the site: the reference lists at the end of our clinical pages are all drawn from the pool described here.
Our approach to evidence
- Critical clinical claims (efficacy, risk, fertility) rest on at least two strong sources — preferably meta-analyses or guidelines.
- Manufacturer documents source device specifications only; they are never used as clinical outcome evidence.
- We do not hide where evidence is limited: uncertainty is part of the decision conversation.
- Every clinical page passes physician review, with the review date displayed.
Main findings of the literature — a summary
Efficacy: pooled analyses show meaningful volume reduction and symptomatic improvement in well-selected patients; NICE considers the short-term efficacy evidence adequate.
Source: 2022 · International Journal of Hyperthermia2011 · NICE (İngiltere Ulusal Sağlık ve Bakım Mükem
Safety and recovery: comparative analyses associate HIFU with shorter hospital stay and lower procedural morbidity than surgery; serious complications are rare.
Source: 2021 · Frontiers in Oncology
Limits: retreatment likelihood is higher than surgery’s on average and strongly selection-dependent; long-term and pregnancy data are still maturing.
These three findings must be read together — any summary telling only one of them is incomplete.
Source: 2024 · International Journal of Hyperthermia2011 · NICE (İngiltere Ulusal Sağlık ve Bakım Mükem
What is in this section?
The studies library holds the full citations of every source we use; the case section will present consented, anonymised real treatment examples as they become available; and expert reviews will carry the clinical team’s commentary.